Metheptazine
Group of stereoisomers
- none
- methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate
- 469-78-3 Y
- 3047717
- 2310051 Y
- 93X4R66P5A
- ChEMBL2104520 N
- DTXSID10861967
- Interactive image
- O=C(OC)C2(c1ccccc1)CC(N(C)CCC2)C
InChI
- InChI=1S/C16H23NO2/c1-13-12-16(15(18)19-3,10-7-11-17(13)2)14-8-5-4-6-9-14/h4-6,8-9,13H,7,10-12H2,1-3H3 Y
- Key:RAAFYFKWMRWOIT-UHFFFAOYSA-N Y
Metheptazine is an opioid analgesic from the phenazepane family. It was developed by American Home Products in the 1950s.[1]
Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the Phenazepine opioids Metheptazine, Ethoheptazine, and Metethoheptazine from control.
References
- ^ US 3316244, Bell SC, Childress SJ, "Process for the preparation of hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylic acid, ethyl ester", issued 25 April 1967, assigned to American Home Products Corporation.
- ^ "Conversion Factors for Controlled Substances". U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division.
- v
- t
- e
Opioid receptor modulators
(MOR)
(DOR)
(KOR)
(NOP)
Agonists |
|
---|---|
Antagonists |
|
- Enkephalinase inhibitors: Amastatin
- BL-2401
- Candoxatril
- D -Phenylalanine
- Dexecadotril (retorphan)
- Ecadotril (sinorphan)
- Kelatorphan
- Racecadotril (acetorphan)
- RB-101
- RB-120
- RB-3007
- Opiorphan
- Selank
- Semax
- Spinorphin
- Thiorphan
- Tynorphin
- Ubenimex (bestatin)
- Propeptides: β-Lipotropin (proendorphin)
- Prodynorphin
- Proenkephalin
- Pronociceptin
- Proopiomelanocortin (POMC)
- Others: Kyotorphin (met-enkephalin releaser/degradation stabilizer)
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e